[HTML][HTML] Retinopathy of prematurity: Past, present and future
PK Shah, V Prabhu, SS Karandikar… - World journal of …, 2016 - ncbi.nlm.nih.gov
Retinopathy of prematurity (ROP) is a vasoproliferative disorder of the retina occurring
principally in new born preterm infants. It is an avoidable cause of childhood blindness. With …
principally in new born preterm infants. It is an avoidable cause of childhood blindness. With …
Wnt Signaling in vascular eye diseases
The Wnt signaling pathway plays a pivotal role in vascular morphogenesis in various organs
including the eye. Wnt ligands and receptors are key regulators of ocular angiogenesis both …
including the eye. Wnt ligands and receptors are key regulators of ocular angiogenesis both …
[HTML][HTML] Animal models of ocular angiogenesis: from development to pathologies
Pathological angiogenesis in the eye is an important feature in the pathophysiology of many
vision-threatening diseases, including retinopathy of prematurity, diabetic retinopathy, and …
vision-threatening diseases, including retinopathy of prematurity, diabetic retinopathy, and …
[WITHDRAWN] retinal vasculature in development and diseases
This article was withdrawn on October 15, 2020, at the request of the journal editors, with
agreement from the authors, owing to a substantial amount of unattributed or improperly …
agreement from the authors, owing to a substantial amount of unattributed or improperly …
Comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity: a randomized clinical trial
A Stahl, TU Krohne, N Eter, I Oberacher-Velten… - JAMA …, 2018 - jamanetwork.com
Importance Anti–vascular endothelial growth factor (VEGF) therapies are a novel treatment
option in retinopathy of prematurity (ROP). Data on dosing, efficacy, and safety are …
option in retinopathy of prematurity (ROP). Data on dosing, efficacy, and safety are …
[HTML][HTML] Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial
YE Vaucher, M Peralta-Carcelen… - … England Journal of …, 2012 - Mass Medical Soc
Background Previous results from our trial of early treatment with continuous positive airway
pressure (CPAP) versus early surfactant treatment in infants showed no significant …
pressure (CPAP) versus early surfactant treatment in infants showed no significant …
[HTML][HTML] The prognostic value of lymphocyte-to-monocyte ratio in retinopathy of prematurity
YX Hu, XX Xu, Y Shao, GL Yuan, F Mei… - International journal …, 2017 - ncbi.nlm.nih.gov
AIM To evaluate the associations between development of retinopathy of prematurity (ROP)
and serum lymphocyte-to-monocyte ratio (LMR), neutrophil-to-lymphocyte ratio (NLR), and …
and serum lymphocyte-to-monocyte ratio (LMR), neutrophil-to-lymphocyte ratio (NLR), and …
NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy
JL Wilkinson-Berka, D Deliyanti, I Rana… - Antioxidants & redox …, 2014 - liebertpub.com
Aims: Ischemic retinal diseases such as retinopathy of prematurity are major causes of
blindness due to damage to the retinal microvasculature. Despite this clinical situation …
blindness due to damage to the retinal microvasculature. Despite this clinical situation …
[HTML][HTML] Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options
FM Mutlu, SU Sarici - International Journal of Ophthalmology, 2013 - ncbi.nlm.nih.gov
Retinopathy of prematurity (ROP), a retinal vascular disease of premature infants, continues
to be a major cause of preventable childhood blindness all over the world. The incidence of …
to be a major cause of preventable childhood blindness all over the world. The incidence of …
In vitro and ex vivo retina angiogenesis assays
Pathological angiogenesis of the retina is a key component of irreversible causes of
blindness, as observed in proliferative diabetic retinopathy, age-related macular …
blindness, as observed in proliferative diabetic retinopathy, age-related macular …